Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health
Metabolites · 24.03.2025 · 15 (4) · 220
DOI: 10.3390/metabo15040220 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Metabolites, online erschienen am 24.03.2025. Verfasst von Eugenio Caradonna und 11 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Laboratory Medicine Services, Centro Diagnostico Italiano S.p.A., 20011 Milan, Italy. Die Arbeit wurde bisher 91-mal zitiert (Crossref) und nennt 170 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The intestinal microbiota, hosting trillions of microorganisms that inhabit the gastrointestinal tract, functions as a symbiotic organism that plays a crucial role in regulating health by producing biologically active molecules that can enter systemic circulation. Among them, trimethylamine-N-oxide (TMAO), an organic compound derived from dietary sources and microbial metabolism, has emerged as a critical biomarker linking diet, the gut microbiota, and the host metabolism to various pathological conditions. This comprehensive review highlights TMAO’s biosynthesis, physiological functions, and clinical significance, focusing on its mechanistic contributions to cardiovascular and neurodegenerative diseases. Notably, TMAO-mediated pathways include endothelial dysfunction, inflammation via NLRP3 inflammasome activation, and cholesterol metabolism disruption, which collectively accelerate atherosclerosis and disease progression. Nonetheless, this work underscores the innovative potential of targeting TMAO through dietary, nutraceutical, and microbiota-modulating strategies to mitigate its pathological effects, marking a transformative approach in the prevention and management of TMAO-related disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Integrated Laboratory Medicine Services, Centro Diagnostico Italiano S.p.A., 20011 Milan, Italy.
- Department of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania Luigi Vanvitelli, Via Vivaldi 43, 81100 Caserta, Italy.
- Inventia Biotech-Healthcare Food Research Center S.r.l., Strada Statale Sannitica KM 20.700, 81020 Caserta, Italy.
- School of Nursing, Cardiovascular Diseases, University of Pavia, 27100 Pavia, Italy.
- Faculty of Medicine, University of Bari, 70121 Bari, Italy.
- Department of Interdisciplinary Medicine, Università Degli Studi di Bari, 70124 Bari, Italy.
ORCID-Profile: Eugenio Caradonna, Federico Abate, Elisabetta Schiano, Fulvio Ferrara, Emilio Vanoli, Bruno Amato, Carlo Setacci, Ettore Novellino
Zitieren
APA
Caradonna, E., Abate, F., Schiano, E., Paparella, F., Ferrara, F., Vanoli, E., Difruscolo, R., Goffredo, V. M., Amato, B., Setacci, C., Setacci, F., & Novellino, E. (2025). Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health. Metabolites, 15(4), 220. https://doi.org/10.3390/metabo15040220
Vancouver
Caradonna E, Abate F, Schiano E, Paparella F, Ferrara F, Vanoli E, et al. Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health. Metabolites. 2025;15(4):220. doi:10.3390/metabo15040220
BibTeX
@article{Caradonna2025,
author = {Caradonna, Eugenio and Abate, Federico and Schiano, Elisabetta and Paparella, Francesca and Ferrara, Fulvio and Vanoli, Emilio and Difruscolo, Rossana and Goffredo, Vito Maria and Amato, Bruno and Setacci, Carlo and Setacci, Francesco and Novellino, Ettore},
title = {Trimethylamine-N-Oxide (TMAO) as a Rising-Star Metabolite: Implications for Human Health},
journal = {Metabolites},
year = {2025},
volume = {15},
number = {4},
pages = {220},
doi = {10.3390/metabo15040220}
}
EUVIMED